Lidothol
NDC 87063-218, LIDOCAINE HCl, MENTHOL, gel, from ASCLEMED USA INC..
- Product NDC
- 87063-218
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- GEL
- Route
- CUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MENTHOL5 g/100g
- LIDOCAINE HYDROCHLORIDE4.5 g/100g
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-218-99 | 87063021899 | 1 TUBE in 1 BOX (87063-218-99) / 99.2 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4e2fad18-13f1-4e61-86db-d72102928717
Use it
Look up 87063-218 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-218. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.